Day one biopharmaceuticals holding company llc
Biotechnology:-Biological-Products-(No-Diagnostic-Substances)
DAWN
Executive/
Director
Links
Price
- Last Close
-
$ 12.58
$ -0.12 -0.94 %
Jan 3, 2025
- 52-Week High/Low
- $17.46 - $9.68
- YTD
- -0.7%
- Trading Volume
- 16,743
- Market Cap Full
- $ 1.1B
- Shares Outstanding
-
87M
Nov 1, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | - | - | -41.1% | -37.9% | 13% | -0.7% |
| Q2 | - | - | - | - | - | -3.1% | 80.4% | -10.7% | -14.4% | - |
| Q3 | - | - | - | - | - | 4.2% | 11.9% | 2.8% | -4.3% | - |
| Q4 | - | - | - | - | - | -29% | 7.4% | 21.6% | -17.5% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -0.7% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 3.1% | 11.2% | -1.4% | -9.2% | -10.3% | 3.1% | 3.3% | -4.3% | - | - | - | -9% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 0% | 0% | 28% | -32% | -13% | -1% |
Earnings
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Q1 | - | -2.58 | -0.48 | -0.59 |
| Q2 | - | -5.04 | -0.6 | -0.61 |
| Q3 | - | -0.33 | -0.53 | -0.54 |
| Q4 | - | 3.33 | -0.56 | - |
| A | -7.3 | -4.6 | -2.2 | -1.74 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Mar | - | 62 | 73.6 |
| Jun | - | 61.9 | 73.6 |
| Sep | 61.9 | 73.5 | 87 |
| Dec | 61.9 | 73.5 | 87 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Asset Management | |||||
| Inventory / Stock Turnover | - | - | - | - | - |
| Fixed Asset Turnover | - | - | - | - | - |
| Total Asset Turnover | - | - | - | - | - |
| Leverage | |||||
| Debt Ratio | - | - | - | - | - |
| Debt – Equity Ratio | - | - | - | - | - |
| Interest Coverage | 29.4 | 36.5 | -0.5 | 7.5 | - |
| Equity multiplier | - | - | - | - | - |